IRIS
RIBOLSI, MENTORE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 3.977
NA - Nord America 803
SA - Sud America 384
EU - Europa 381
AF - Africa 43
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.601
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 3.035
US - Stati Uniti d'America 724
CN - Cina 426
BR - Brasile 286
VN - Vietnam 220
HK - Hong Kong 189
IT - Italia 109
GB - Regno Unito 96
DE - Germania 56
AR - Argentina 45
MX - Messico 36
CA - Canada 32
IN - India 24
ZA - Sudafrica 21
NL - Olanda 20
ID - Indonesia 19
EC - Ecuador 18
FI - Finlandia 14
FR - Francia 11
PE - Perù 11
AU - Australia 10
BD - Bangladesh 10
PL - Polonia 10
UA - Ucraina 10
ES - Italia 9
PK - Pakistan 9
CO - Colombia 8
CZ - Repubblica Ceca 8
JP - Giappone 8
AT - Austria 7
EG - Egitto 6
PY - Paraguay 6
EE - Estonia 5
RU - Federazione Russa 5
ET - Etiopia 4
KZ - Kazakistan 4
SE - Svezia 4
UZ - Uzbekistan 4
VE - Venezuela 4
CL - Cile 3
IR - Iran 3
PT - Portogallo 3
RO - Romania 3
TR - Turchia 3
AE - Emirati Arabi Uniti 2
BE - Belgio 2
DO - Repubblica Dominicana 2
HU - Ungheria 2
KE - Kenya 2
KR - Corea 2
MA - Marocco 2
ML - Mali 2
TH - Thailandia 2
TW - Taiwan 2
UY - Uruguay 2
AL - Albania 1
AM - Armenia 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BZ - Belize 1
CG - Congo 1
CR - Costa Rica 1
CY - Cipro 1
DM - Dominica 1
GA - Gabon 1
GT - Guatemala 1
HN - Honduras 1
IM - Isola di Man 1
IQ - Iraq 1
JM - Giamaica 1
JO - Giordania 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LC - Santa Lucia 1
LT - Lituania 1
ME - Montenegro 1
MY - Malesia 1
NG - Nigeria 1
NP - Nepal 1
NR - Nauru 1
OM - Oman 1
PH - Filippine 1
PR - Porto Rico 1
PW - Palau 1
QA - Qatar 1
RS - Serbia 1
SA - Arabia Saudita 1
SI - Slovenia 1
SN - Senegal 1
SV - El Salvador 1
TZ - Tanzania 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZW - Zimbabwe 1
Totale 5.601
Salva come PNG Salva come JPEG
Città #
Singapore 312
Ashburn 208
Hong Kong 182
Hefei 171
Ho Chi Minh City 91
Beijing 90
Boardman 82
London 79
Dallas 69
Shanghai 49
Hanoi 45
Rome 39
Council Bluffs 33
Los Angeles 31
Santa Clara 30
Munich 29
Mexico City 22
São Paulo 22
Burlington 18
New York 14
Pune 13
San Francisco 13
Seattle 13
Brooklyn 12
Haiphong 11
Amsterdam 10
Johannesburg 10
West Jordan 10
Chicago 9
Turku 9
Warsaw 9
Washington 9
Buffalo 8
Denver 8
Guarulhos 8
San Jose 8
Secaucus 8
Biên Hòa 7
Curitiba 7
Da Nang 7
Guayaquil 7
Rio de Janeiro 7
Thái Bình 7
Toronto 7
Campinas 6
Guangzhou 6
Lima 6
Quito 6
Bologna 5
Helsinki 5
Milan 5
Ninh Bình 5
Ribeirão Preto 5
Atlanta 4
Belo Horizonte 4
Brno 4
Chengdu 4
Chennai 4
Dhaka 4
Hangzhou 4
Paris 4
Phoenix 4
Sona 4
Stockholm 4
Thái Nguyên 4
Tokyo 4
Vĩnh Tường 4
Addis Ababa 3
Alvorada 3
Barra Bonita 3
Bauru 3
Boydton 3
Brasília 3
Córdoba 3
Frankfurt am Main 3
Guiyang 3
Hamburg 3
Lấp Vò 3
Manaus 3
Melbourne 3
Novo Hamburgo 3
Olomouc 3
Palermo 3
Rio Claro 3
Salvador 3
San Juan 3
Santa Fe 3
Tashkent 3
Vienna 3
Volla 3
Adelaide 2
Asunción 2
Bangkok 2
Banī Suwayf 2
Bogotá 2
Bolzano 2
Boston 2
Brescia 2
Brookline 2
Brussels 2
Totale 2.027
Salva come PNG Salva come JPEG
Nome #
Dilated intercellular spaces of esophageal epithelium in nonerosive reflux disease patients with physiological esophageal acid exposure 218
Colonic Epithelial Permeability to Ions Is Restored after Vedolizumab Treatment and May Predict Clinical Response in Inflammatory Bowel Disease Patients 208
Applying Lyon Consensus criteria in the work‐up of patients with proton pump inhibitory‐refractory heartburn 207
Anti-tumor necrosis factor-alpha reverts growth hormone resistance associated with inflammatory bowel disease 203
Novel impedance-pH parameters are associated with proton pump inhibitor response in patients with inconclusive diagnosis of gastro-oesophageal reflux disease according to Lyon Consensus 199
Effect of oesophagitis on proximal extent of gastro-oesophageal reflux. 194
Clinical impact of proton pump inhibitor response and dependence 192
Effect of the gatekeeper reflux repair system on intra-esophageal distribution of acid reflux in gastroesophageal reflux disease patients: Relation with typical symptoms 191
Correlation between reflux burden, peristaltic function, and mucosal integrity in GERD patients 183
Chicago Classification v4.0 Stratifies Acid Burden and Abnormal Impedance-pH Variables Better Than Chicago Classification v3.0 Chicago Classification v4.0 and GERD 124
Achalasia, from diagnosis to treatment 119
Association between dietary habits and fecal microbiota composition in irritable bowel syndrome patients: A pilot study 115
Wall Thickness Ratio—A New Magnetic Resonance Parameter—Is Associated With the Outcome of Biological Therapy in Patients With Ileal and Ileocolonic Crohn’s Disease 114
Association between post-reflux swallow-induced peristaltic wave index and esophageal mucosal integrity in patients with GERD symptoms 113
Application of Lyon Consensus criteria for GORD diagnosis: evaluation of conventional and new impedance-pH parameters 112
Anxiety correlates with excessive air swallowing and PPI refractoriness in patients with concomitant symptoms of GERD and functional dyspepsia 105
Acid reflux episodes sensitize the esophagus to perception of weakly acidic and mixed reflux in non-erosive reflux disease patients 104
Breathing training on lower esophageal sphincter as a complementary treatment of gastroesophageal reflux disease (GERD): a systematic review 99
Dynamic contrast enhanced magnetic resonance imaging of the terminal ileum: differentiation of activity of Crohn’s disease 99
Effect of endoscopic augmentation of the lower oesophageal sphincter (Gatekeeper reflux repair system) on intraoesophageal dynamic characteristics of acid reflux 96
Effect of hiatal hernia on proximal oesophageal acid clearance in gastro-oesophageal reflux disease patients 88
Esophageal pH increments associated with post-reflux swallow-induced peristaltic waves show the occurrence and relevance of esophago-salivary reflex in clinical setting 87
Impedance baseline and reflux perception in responder and non-responder non-erosive reflux disease patients 84
Dilated intercellular spaces and acid reflux at the distal and proximal oesophagus in patients with non-erosive gastro-oesophageal reflux disease 71
Impaired colonic contractility and intestinal permeability in symptomatic uncomplicated diverticular disease 70
Esophageal and Oropharyngeal Dysphagia: Clinical Recommendations From the United European Gastroenterology and European Society for Neurogastroenterology and Motility 59
Mechanisms of action of prebiotics and their effects on gastro-intestinal disorders in adults 58
Palmitic acid affects intestinal epithelial barrier integrity and permeability in vitro 47
Psychological distress in inflammatory bowel disease 47
Impedance-High Resolution Manometry Analysis of Patients With Nonerosive Reflux Disease 45
The 1st EoETALY Consensus on the Diagnosis and Management of Eosinophilic Esophagitis – Definition, Clinical Presentation and Diagnosis 44
Prospective validation of reflux monitoring by impedance-pH in predicting PPI response in typical GERD 44
Nutritional status and bioelectrical phase angle assessment in adult Crohn disease patients receiving anti-TNFα therapy 43
Italian guidelines for the diagnosis and management of gastro-esophageal reflux disease: Joint consensus from the Italian Societies of: Gastroenterology and Endoscopy (SIGE), Neurogastroenterology and Motility (SINGEM), Hospital Gastroenterologists and Endoscopists (AIGO), Digestive Endoscopy (SIED), and General Medicine (SIMG) 42
Reflux pattern and role of impedance-pH variables in predicting PPI response in patients with suspected GERD-related chronic cough. 41
Diagnostic delay and misdiagnosis in eosinophilic oesophagitis 39
The Results From Up-Front Esophageal Testing Predict Proton Pump Inhibitor Response in Patients With Chronic Cough 39
Baseline impedance levels and structural and functional integrity of the esophageal mucosa: is acid still the only player? 39
Topical Protection of Esophageal Mucosa as a New Treatment of GERD 39
The 1st EoETALY Consensus on the Diagnosis and Management of Eosinophilic Esophagitis–Current Treatment and Monitoring 38
Patients With Definite and Inconclusive Evidence of Reflux According to Lyon Consensus Display Similar Motility and Esophagogastric Junction Characteristics 37
Esophageal chest pain resembles heartburn in reflux metrics and response to proton pump inhibitor therapy 36
Ambulatory reflux monitoring for diagnosis of gastro-esophageal reflux disease: Update of the Porto consensus and recommendations from an international consensus group 36
Dilated intercellular space diameter as marker of reflux-related mucosal injury in children with chronic cough and gastro-oesophageal reflux disease 36
Intra-oesophageal distribution and perception of acid reflux in patients with non-erosive gastro-oesophageal reflux disease 35
Infliximab reverses growth hormone resistance associated with inflammatory bowel disease 34
Esophageal motility disorders among elderly patients: An international multicenter study 32
Intra-bolus pressure and esophagogastric gradient, assessed with high-resolution manometry, are associated with acid exposure and proximal migration of refluxate 32
Artificial Intelligence in the Diagnosis of Upper Gastrointestinal Diseases 32
Pharmacological management of gastro-esophageal reflux disease: state of the art in 2024 32
An update of pharmacology, efficacy, and safety of vonoprazan in acid-related disorders 31
The Lyon Consensus: Does It Differ From the Previous Ones? 31
Normal values and regional differences in oesophageal impedance-pH metrics: a consensus analysis of impedance-pH studies from around the world 31
Editorial: inconclusive diagnosis of GERD: are new parameters in impedance‐pHmetry ready for clinical use? Authors' reply 30
Weak peristalsis with large breaks is associated with higher acid exposure and delayed reflux clearance in the supine position in GERD patients 30
Prevalence and clinical characteristics of refractoriness to optimal proton pump inhibitor therapy in non-erosive reflux disease 30
Advancements in the use of 24-hour impedance-pH monitoring for GERD diagnosis 29
Platelet-activating factor and distinct chemokines are elevated in mucosal biopsies of erosive compared with non-erosive reflux disease patients and controls 29
Nutritional aspects in inflammatory bowel diseases 29
Role of Esophageal Motility, Acid Reflux, and of Acid Suppression in Nonobstructive Dysphagia 29
High-resolution Manometry Findings During Solid Swallows Correlate With Delayed Reflux Clearance and Acid Exposure Time in Non-erosive Reflux Disease Patients 29
Exploring the association between esophageal mucosal inflammation, impaired motility, and GERD severity 28
Exploring the Complex Interplay Between Ineffective Esophageal Motility and Reflux Burden 28
Relevance of Excessive Air Swallowing in GERD Patients With Concomitant Functional Dyspepsia and Poor Response to PPI Therapy 28
Increased frequency and enhanced perception of reflux in non-erosive reflux disease patients non-responder to proton pump inhibitors 28
PATIENTS WITH EXTRA-ESOPHAGEAL SYMPTOMS, COMPARED TO NERD PATIENTS WITH TYPICAL SYMPTOMS AND HEALTHY VOLUNTEERS, ARE CHARACTERIZED BY A HIGHER NUMBER OF REFLUX EPISODES AND HIGHER PROPORTION OF WEAKLY ACIDIC AND MIXED REFLUX 28
Letter: is wireless oesophageal pH monitoring the best technique to evaluate night‐time reflux? 27
Modern Diagnosis of Early Esophageal Cancer: From Blood Biomarkers to Advanced Endoscopy and Artificial Intelligence 27
Practice guidelines on the use of esophageal manometry – A GISMAD-SIGE-AIGO medical position statement 27
Should we have to include transcutaneous neuromodulation in the therapeutic GERD armamentarium? 27
Letter to the Editor: Relevance of a Correct GERD Patient Classification Before Anti-reflux Procedures 27
High-resolution Manometry Determinants of Refractoriness of Reflux Symptoms to Proton Pump Inhibitor Therapy 27
Classification of esophageal motor findings in gastro-esophageal reflux disease: Conclusions from an international consensus group 27
Proximal esophageal impedance baseline increases the yield of impedance‐pH and is associated with response to PPIs in chronic cough patients 27
Encouraging appropriate use of proton pump inhibitors: existing initiatives and proposals for the future 26
Towards a better diagnosis of gastro esophageal reflux disease 26
Nonachalasic esophageal motor disorders, from diagnosis to therapy 26
Letter: the potential link between oesophageal hypervigilance, visceral anxiety, increased swallow rate and oesophageal mucosal integrity 26
The Clinical Spectrum of Gastroesophageal Reflux Disease: Facts and Fictions 25
Editorial: Lyon consensus metrics—towards personalised diagnosis of non‐erosive reflux disease: Authors' reply 25
On‐therapy impedance‐pH monitoring can efficiently characterize PPI‐refractory GERD and support treatment escalation 25
Reflux characteristics triggering post-reflux swallow-induced peristaltic wave (PSPW) in patients with GERD symptoms 25
Role of Overweight and Obesity in Gastrointestinal Disease 25
Role of Mixed Reflux and Hypomotility with Delayed Reflux Clearance in Patients with Non-cardiac Chest Pain 25
Proximal esophageal impedance baseline increases the yield of impedance-pH monitoring for GERD diagnosis and is associated with heartburn response to PPI 24
Post-reflux swallow-induced peristaltic wave index and mean nocturnal baseline impedance predict PPI response in GERD patients with extra esophageal symptoms 24
Postreflux swallow-induced peristaltic wave index from pH-impedance monitoring associates with esophageal body motility and esophageal acid burden 24
New classifications of gastroesophageal reflux disease: an improvement for patient management? 23
Letter: should we have to include baclofen in the GORD therapy armamentarium? 21
Proton pump inhibitor resistance, the real challenge in gastro-esophageal reflux disease 21
Understanding the relationship between esophageal motor disorders and reflux disease 21
Presence of gas in the refluxate enhances reflux perception in non-erosive patients with physiological acid exposure of the oesophagus 21
Maintenance of remission with infliximab in inflammatory bowel disease: Efficacy and safety long-term follow-up 20
Fragmented and failed swallows on esophageal high-resolution manometry associate with abnormal reflux burden better than weak swallows 20
Measurement of acid exposure of proximal esophagus: a better tool for diagnosing non-erosive reflux disease 19
Relationship between baseline impedance levels and esophageal mucosal integrity in children with erosive and non-erosive reflux disease 19
Regional oesophageal sensitivity to acid and weakly acidic reflux in patients with non-erosive reflux disease 19
Intercellular space diameters of the oesophageal epithelium in NERD patients: head to head comparision between light and electron microscopy 19
Short duration of acid exposure sensitizes the esophagus to perception of weakly acidic and mixed reflux in non-erosive reflux disease (NERD) patients 18
Oesophageal mucosal intercellular space diameter and reflux pattern in childhood erosive and non-erosive reflux disease 14
Totale 5.666
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.721
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.721
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202283 0 0 2 0 0 2 0 2 0 3 0 74
2022/202333 1 0 0 2 0 1 0 2 0 0 27 0
2023/2024331 5 35 42 23 18 137 3 27 3 17 15 6
2024/20253.468 39 24 117 26 42 75 62 16 230 208 1.127 1.502
2025/20261.751 355 199 298 586 171 142 0 0 0 0 0 0
Totale 5.666